Clinical Trials Logo

Filter by:
NCT ID: NCT02362503 Active, not recruiting - HIV Infections Clinical Trials

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Start date: February 23, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.

NCT ID: NCT02361801 Completed - Coronary Disease Clinical Trials

Liberal Versus Restrictive Use of Dobutamine in Cardiac Surgery

DOBUTACS
Start date: February 2015
Phase: Phase 3
Study type: Interventional

Inotropic agents are usually administered in the postoperative period after cardiac surgery. In most cases, dobutamine is administered routinely, for the probable occurrence of myocardial dysfunction after cardiopulmonary bypass or a low cardiac output with minimal evidence of altered tissue perfusion. Recent data show that inotropic agents are used in 35-52% of cardiac surgeries in the perioperative period. However, the use of inotropic agents may be associated with adverse events, including myocardial ischemia, by elevation in myocardial oxygen consumption and the imbalance between supply and consumption, and tachyarrhythmias (atrial fibrillation, sinus tachycardia, ventricular tachyarrhythmias), primarily due to the β1-adrenergic effect. This study is a non-inferiority clinical randomized study aiming to compare the use of dobutamine in a liberal strategy (in all patients at the time of withdrawal of CPB) with a restrictive strategy (based on clinical and hemodynamic evidence of low cardiac output syndrome associated with altered tissue perfusion). Our primary hypothesis is that the restrictive use of dobutamine is as safe and effective as the liberal one.

NCT ID: NCT02360462 Completed - Chronic Pain Clinical Trials

The Effect of tDCS in the Preoperative Period of Hallux Valgus Surgical Treatment

Start date: December 2014
Phase: N/A
Study type: Interventional

This is a clinical trial that intend to determine if transcranial direct current stimulation (tDCS) is effective in the treatment of postoperative pain and in the anxiety level in the preoperative period of hallux valgus surgical treatment

NCT ID: NCT02357693 Completed - Clinical trials for Postoperative Nausea and Vomiting

Neurokinin Receptor Antagonist Associated to Ondansetron in PONV

PONV
Start date: February 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether patients at high risk for postoperative nausea and vomiting can benefit from aprepitant, ondansetron and dexamethasone in the perioperative period.

NCT ID: NCT02354508 Completed - Acromegaly Clinical Trials

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Start date: March 31, 2015
Phase: Phase 3
Study type: Interventional

This is a phase IIIb multicenter, open-label; single arm study to evaluate the efficacy and safety of pasireotide LAR 40 mg and 60 mg in patients with inadequately controlled acromegaly with maximal approved doses of first generation somatostatin analogues. The study will enroll inadequately controlled patients by high doses (maximal approved) of first-generation somatostatin analogues given for at least 3 months. Patients will receive pasireotide LAR 40 mg or 60 mg during the 36 week core study phase. Patients who have completed all visits of core phase and have completed all the assessments at the core phase completion visit can move into the 32-week extension phase. Patients can continue with study treatment until pasireotide LAR is commercially available and reimbursed in their respective country or until the end of the extension phase whichever occurs first.

NCT ID: NCT02353897 Completed - Glabellar Lines Clinical Trials

Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®

APPEAL
Start date: October 2014
Phase:
Study type: Observational

This study aims to look at patient and physician satisfaction of long term Glabellar lines (GL) treatment with Dysport in a real life setting. It will also allow better understanding of what patients expect from the treatment, and the injection practices used by doctors.

NCT ID: NCT02353442 Enrolling by invitation - Shoulder Pain Clinical Trials

Changes in Subjects With Posterior Capsule Tightness

Start date: March 2015
Phase: Phase 0
Study type: Interventional

To identify biomechanical and sensibility changes in people with posterior capsule tightness in people with and without shoulder pain.

NCT ID: NCT02351986 Completed - Pain Clinical Trials

Effects of Cryotherapy on Joint Function and Pressure Pain Threshold in Patients With Subacromial Impingement Syndrome.

Start date: June 2014
Phase: N/A
Study type: Interventional

Background: Subacromial impingement syndrome (SIS) is a chronic and disabling disease, characterized by compression and mechanical abrasion of the tendons of the rotator cuff muscles, subacromial bursa and tendon of the long head of the biceps against the anterior surface of the acromion, coracoacromial ligament or the acromioclavicular joint during arm elevation movement. After the trauma, inflammatory processes initiate and may lead to loss of function when untreated. This inflammation leads the release of cytokines (IL-6, IL-10, IL-1β and TNF-α) whose acts as inflammatory mediators. Physical therapy works in treating SIS with the goal of reducing pain and inflammatory process. Cryotherapy is widely used in physical therapy by anti-inflammatory and analgesic effects, low cost, effectiveness and easy application. Objective: The aim of the study is to evaluate the effects of a cryotherapy protocol, applied on shoulder of subjects with SIS, on serum inflammatory mediators (cytokines) and local pressure pain threshold. Possible changes in function and pain will also be evaluated. Materials and Methods: 30 subjects will be selected and share in two groups, 15 healthy subjects and 15 subjects with SIS. Function assessments and quality of life will be held using the DASH and WORC questionnaires. Cryotherapy will be applied for 4 consecutive days, lasting 20 minutes without interruption through ice pack over the shoulder of SIS carriers. For the blood samples, 20ml of blood will be collected at the first and last day of the intervention, and then stored at -80 ° C.

NCT ID: NCT02348151 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Shuttle Walk Test Performed on a Treadmill Versus a Corridor in Patients With COPD

(SWTiCOPD)
Start date: January 2014
Phase: N/A
Study type: Interventional

It is still not clearly known whether doing the walk test in a course is different from doing it on a treadmill in the lack of a ten-meter-long corridor. In case of a positive outcome in this study, we will have an alternative for this test in places where there is not enough room, benefiting the assessment of COPD patients' functional capacity. In the literature, there are still some controversies about performing the test on a treadmill or in a corridor and whether there is interference with the distance walked. Our hypothesis is that there is no interference with the distance walked, and thus we have one more option to perform the test in case there is no 10-meter corridor available.

NCT ID: NCT02348138 Completed - Hypertension Clinical Trials

Effect of Isometric Handgrip Training on Cardiovascular Risk in Hypertensives

Start date: June 2015
Phase: N/A
Study type: Interventional

The main purpose this study is to analyze the effects of isometric handgrip training on cardiovascular risk in hypertensive. For this, approximately 60 hypertensive, under anti-hypertensive medication, will be selected and randomly distributed into three groups: home-based isometric handgrip training (HBT), supervised isometric handgrip training (ST) and control group (CG).Subjects assigned to the HBT and ST will train three times per week for a total of 12 weeks, will perform a bout of isometric handgrip exercise: four sets of 2-min isometric contractions (using alternate hands) at 30% of maximal voluntary contraction. However, the subjects of the HBT group conduct the training without daily supervision. Subjects randomized to the CG will be encouraged to increase the level of physical activity and make healthy eating, without, however, receive specific recommendations.Baseline and after 12 weeks of intervention, the following cardiovascular risk indicators will be obtained: blood pressure, arterial stiffness, cardiac autonomic modulation, vasodilatory capacity and oxidative and inflammatory stress markers, in addition to microalbuminuria. For data analysis, in addition to descriptive statistics, two-way ANOVA for mixed model will be applied for within and between groups comparison. If the premises of this test are met. The level of significance that will be adopted is p<0.05.